INWORKS and Hiroshima/Nagasaki Leukaemia Results
10 Key Points
-
Hiroshima/Nagasaki studies show no rise in leukemia below ~200 mGy.
-
INWORKS claimed worker leukemia risks even below 100 mGy.
-
That claim clashes with expectations since H/N doses were higher and included children.
-
Closer look shows only Chronic Myeloid Leukemia (CML) rises with dose in INWORKS.
-
Other types (ALL, AML, CLL) show no link or even negative trends.
-
Pooling them together (as INWORKS did) is misleading.
-
The “risk” comes from just 8 high-dose CML deaths, most at very old ages.
-
Threshold fits better: no leukemia increase below ~200 mGy.
-
The few possible work-related CML cases might involve high, short-term exposures or chemicals.
-
Conclusion: no evidence low protracted doses (<200 mGy) cause leukemia in either workers or H/N survivors